---
title: "Dian Diagnostics has reached a cooperation with Sir Run Run Shaw Hospital to jointly promote the transformation of medical achievements related to immunotherapy biomarkers for hepatocellular carcinoma"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256891267.md"
description: "Dian Diagnostics signed a cooperation agreement with Sir Run Run Shaw Hospital on September 11 to jointly promote the medical transformation of immunotherapy biomarkers for hepatocellular carcinoma. The project focuses on utilizing omics and AI technology to construct a new subtype identification model for HCC based on 29 genes, significantly improving the response rate to immunotherapy. This achievement helps to screen potential beneficiary patients and save medical resources. Currently, relevant nationwide multicenter studies are underway"
datetime: "2025-09-11T10:02:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256891267.md)
  - [en](https://longbridge.com/en/news/256891267.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256891267.md)
---

# Dian Diagnostics has reached a cooperation with Sir Run Run Shaw Hospital to jointly promote the transformation of medical achievements related to immunotherapy biomarkers for hepatocellular carcinoma

On September 11th, Dian Diagnostics Technology Group Co., Ltd. signed a transformation project agreement with the Sir Run Run Shaw Hospital affiliated with Zhejiang University School of Medicine for "A Gene Model Construction Method and Application for Identifying New Subtypes of Hepatocellular Carcinoma," jointly promoting the transformation of medical achievements related to immunotherapy biomarkers for hepatocellular carcinoma. The results of this transformation focus on utilizing omics and AI technology to construct a new subtype identification model for HCC based on 29 genes. The immunotherapy response rate for patients with this subtype is significantly higher than that of non-HCC-1 subtype patients. This achievement helps to screen potential beneficiaries of immunotherapy, avoid ineffective treatments, and save medical resources. Currently, a nationwide multi-center study based on this project is underway

### Related Stocks

- [300244.CN](https://longbridge.com/en/quote/300244.CN.md)

## Related News & Research

- [Is RFK Jr.'s 'carnivore diet' healthy? Here's what you need to know.](https://longbridge.com/en/news/287079002.md)
- [Guriev: Russia is in need of a pipeline to China](https://longbridge.com/en/news/286935918.md)
- [Oil little changed as traders await breakthrough in US.-Iran negotiations](https://longbridge.com/en/news/286925961.md)
- [International Energy Agency Is Wrong To Forecast Coal's Demise](https://longbridge.com/en/news/286899857.md)
- [10:19 ETAARC-360 Completes AICPA Peer Review with Pass Rating](https://longbridge.com/en/news/286929747.md)